Nj State Employees Deferred Compensation Plan Ionis Pharmaceuticals Inc Transaction History
Nj State Employees Deferred Compensation Plan
- $800 Million
- Q4 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 42,000 shares of IONS stock, worth $1.29 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
42,000
Previous 42,000
-0.0%
Holding current value
$1.29 Million
Previous $1.68 Million
12.72%
% of portfolio
0.18%
Previous 0.2%
Shares
7 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$506 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$435 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$352 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$317 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$242 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.36B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...